These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3121845)

  • 1. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.
    Cory-Slechta DA; Weiss B; Cox C
    J Pharmacol Exp Ther; 1987 Dec; 243(3):804-13. PubMed ID: 3121845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children.
    Thomas DJ; Chisolm J
    J Pharmacol Exp Ther; 1986 Dec; 239(3):829-35. PubMed ID: 3098962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL; Lasman J; Smith DR
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):153-60. PubMed ID: 10486301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of edetate and thiamine for treatment of experimentally induced environmental lead poisoning in cattle.
    Coppock RW; Wagner WC; Reynolds JD; Vogel RS; Gelberg HB; Florence LZ; Wolff WA
    Am J Vet Res; 1991 Nov; 52(11):1860-5. PubMed ID: 1785729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential trace metal excretion from rats with lead exposure and during chelation therapy.
    Victery W; Miller CR; Goyer RA
    J Lab Clin Med; 1986 Feb; 107(2):129-35. PubMed ID: 3080537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple dose exposure effects on the tissue distribution of lead in the preweanling rat.
    Massaro EJ; Miller GD; Massaro TF
    Neurotoxicology; 1984; 5(3):333-51. PubMed ID: 6542980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of repeated administration of calcium disodium ethylenediaminetetraacetate during excessive exposure to lead in rats.
    Goyer RA; Cherian MG; Delaquerriere-Richardson L
    J Environ Pathol Toxicol; 1978; 1(4):403-10. PubMed ID: 102714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation of lead during co-exposure to ethanol.
    Dhawan M; Flora SJ; Singh S; Tandon SK
    Biochem Int; 1989 Nov; 19(5):1067-75. PubMed ID: 2561440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute and chronic oval exposure of lead on blood pressure and bone mineral density in rats.
    Bagchi D; Preuss HG
    J Inorg Biochem; 2005 May; 99(5):1155-64. PubMed ID: 15833339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
    J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.